康辰药业：高管拟减持不超0.22%

Core Viewpoint - The company announced that senior management personnel Niu Zhanqi plans to reduce his shareholding due to personal funding needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections - Share Reduction Details - Niu Zhanqi intends to reduce his holdings by up to 87,500 shares, which represents 25% of his total shares and 0.22% of the company's total share capital [1] - The reduction period is set from September 18, 2025, to December 17, 2025 [1] - The shares to be sold are from the company's 2023 restricted stock incentive plan that has had its restrictions lifted [1]